Mycophenolatemofetil in ocular immunological disorders. A survey of the literature with 3 case reports;Mycophenolatmofetil (CellCept®) bei okularen immunologischen storungen. Literaturubersicht mit 3 kasuistiken

Klinische Monatsblatter fur Augenheilkunde

Volumn 213, Issue 5, 1998, Pages 257-261

  Reis, Alexander ^a   Reinhard, Thomas ^a   Sundmacher, Rainer ^a   Althaus, Christoph ^a   Voiculescu, Adina ^a   Kutkuhn, Bernd ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Immunosuppression; Keratoplasty; Mycophenolatemofetil

Indexed keywords

CYCLOSPORIN A; MYCOPHENOLIC ACID; CYCLOSPORIN; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

CASE REPORT; EYE DISEASE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KERATOPLASTY; KIDNEY TRANSPLANTATION; REVIEW; CORNEA TRANSPLANTATION; DRUG HYPERSENSITIVITY; FEMALE; IMMUNOLOGY; MALE; MUCOUS MEMBRANE PEMPHIGOID;

CORNEAL TRANSPLANTATION; CYCLOSPORINE; DRUG HYPERSENSITIVITY; EYE DISEASES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MYCOPHENOLIC ACID; PEMPHIGOID, BENIGN MUCOUS MEMBRANE;

EID: 0032407223     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1034985     Document Type: Review

References (28)

1. Ahsan N, Holman MJ, Katz DA, Abendroth CS, Yang HC, Successful reversal of acute vascular rejection in a renal allograft with combined mycophenolate mofetil and tacrolimus as primary immunotherapy. Clin Transplant 1997 Apr; 11 (2): 94-97
2. Allison A, Hovi R, Watts A, Webster A. The role of de novo purine synthesis in lymphocyte transformation.Ciba Found Symp 1977; 48:207
3. Allison AC, Eugui EM. Mycophenolate mofetil, a rationally designed immunosuppressive drug. Clin Transplantation 1993; 7:96-112
4. Allison AC, Eugui EM. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF). Clin-Transplant 1996 Feb; 10 (1 Pt 2):77-84
5. Bullingham R, Shah J, Goldblum R, Schiff M. Effects of food and antacid on the pharmacokinetics of single doses of mycophenolate mofetil in rheumatoid arthritis patients. Br J Clin Pharmacol 1996 Jun; 41 (6):513-516
6. Carl S, Wiesel M. Mycophenolate mofetil (Cellcept) in renal transplantation: the European experience. The European Mycophenolate Mofetil Co-operative Study Group. Transplant-Proc 1997 Nov; 29 (7):2932-2935
7. Chanaud NP, Vistica B, Eugui E, Nussenblatt RB, Allison AC, Gery I. Inhibition of experimental autoimmune uveoretinitis by mycophenolate mofetil an inhibitor of purine metabolism. Exp Eye Res 1995; 61:429-434
8. Confavreux C, Moreau T. Emerging treatments in multiple sclerosis: azathioprine and mofetil. Mult Scler 1996 Jul; 1 (6):379-384
9. Corna D, Morigi M, Facchinetti D, Bertani T, Zoja C, Remuzzi G. Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease. Kidney-Int 1997 May; 51 (5):1583-1589
10. Deierhoi M, Sollinter H, Diethelm A, et al. One-year follow-up results of a phase 1 trial of mycophenolate mofetil (RS-61443) in cadaveric renal transplantation. Transplant Proc 1993; 25:693f.
11. Ehrlich P, Morgenroth J. Ueber Haemolysine. Berl Klin Wochenschr 1900:453-458
12. Goldblum R. Therapy of rheumatoid arthritis with Mycophenolate Mofetil. Clin Exp Rheumatol 1993; 11 Suppl 8:S117-119
13. Gomez EC, Menendez L, Frost P. Efficacy of Mycophenolic acid for the treatment of psoriasis. J Am Acad Dermatol 1979; 1:531-537
14. Halloran P, Mathew T, Tomlanovich S, Groth C, Hooftman L, Barker C. Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. Transplantation 1997; 63(1):39-47
15. Klintmalm G, Ascher N, Busuth R, et al. RS-61443 treatment for treatment resistant human liver rejection. Transplant Proc 1993; 25:1914f.
16. Longman LJ, LeGatt DF, Halloran PF, Yatscoff RW. Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression in renal transplant recipients. Transplantation 1996; 62(5):666-672
17. Mondino BJ. Bullous diseases of the skin and mucous membranes. Duanes Clinical Ophthalmology 1989, Vol 4, Chap 12, pp 1-16. Hagerstown, MD, Harper & Row
18. Morris R, Hoyt E, Murphy P. Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halts heart allograft rejection by selevtive inhibition of T- and B-cell purine synthesis. Transplant Proc 1990:1659
19. Pirsch JD, Sollinger HW. Mycophenolate mofetil - clinical and experimental experience. Ther-Drug-Monit 1996 Aug; 18 (4):357-361
20. Reinhard T, Sundmacher R, Heering P. Systemic ciclosporin A in high risk keratoplasties. Graefe's Arch Clin Exp Ophthalmol 1996; 234:115-121
21. Reis A, Reinhard T, Braunstein C, Godehardt E, Sundmacher R. Die immunsuppressive Wirkung von Tacrolimus und Mycophenolatemofetil nach allogener Hornhauttransplantation. Tx Med 1998; 10:97-101
22. Renlund DG, Gopinathan SK, Kfoury AG, Taylor DO. Mycophenolate mofetil (MMF) in heart transplantation: rejection prevention and treatment. Clin-Transplant 1996 Feb; 10 (1 Pt 2):136-139
23. Rice BA, Foster CS. Immunopathology of cicatricial pemphigoid affecting the conjunctiva. Ophthalmology 1990; 97:1476
24. Sollinger HW. Update on preclinical and clinical experience with mycophenolate mofetil. Transplant-Proc 1996 Dec; 28 (6 Suppl 1):24-29
25. Streilein JW. Immune regulation and the eye: a dangerous compromise. FASEB J 1987; 1:199-208
26. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 1996 Apr 15; 61 (7):1029-1037
27. Tomlanovich SJ. Rescue therapy with mycophenolate mofetil. Mycophenolate Mofetil Renal Refractory Rejection Study Group. Transplant-Proc 1996 Dec; 28 (6 Suppl 1):34-36
28. Tsina I, Kaloostian M, Lee R, Tarnowski T, Wong B. High-performance liquid chromatographic method for the determination of mycophenolate mofetil in human plasma. J-Chromatogr-B-Biomed-Appl 1996; 681 (2):347-353